{"id":"W1973823302","doi":"10.1158/0008-5472.sabcs12-s6-6","title":"Abstract S6-6: A Phase III, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eribulin; Capecitabine; Medicine; Taxane; Internal medicine; Metastatic breast cancer; Oncology; Clinical endpoint; Anthracycline; Breast cancer; Phases of clinical research; Cancer; Randomized controlled trial; Clinical trial; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002825531,0.002670687,0.003076602,0.0005816485,0.0007535922,0.001288051,0.001307715,0.002320806,0.01094613],"category_scores_gemma":[0.001765274,0.001011702,0.002013078,0.0005521791,0.001735747,0.001497075,0.0005276077,0.005471062,0.00217722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000850199,"about_ca_system_score_gemma":0.002198847,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009207508,"about_ca_topic_score_gemma":0.002176916,"domain_scores_codex":[0.9992267,0.0004439196,0.00005013523,0.0001150051,0.00005343314,0.0001107667],"domain_scores_gemma":[0.9985536,0.0002658379,0.0002788993,0.00008417705,0.00009854358,0.000718885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.953639,0.02945571,0.0006343417,0.0003665776,0.0004818597,0.00005462073,0.00007368433,0.0003749873,0.006875777,0.00008193158,0.0007758372,0.007185679],"study_design_scores_gemma":[0.878036,0.1201191,0.0007539665,0.00001137944,0.0001214469,0.00002090253,0.00001469838,0.0002109804,0.0003521981,0.00005136926,0.0003006609,0.000007329952],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9820148,0.001683076,0.000792344,0.0009982865,0.0004597387,0.01057109,0.001645432,0.00014079,0.001694565],"genre_scores_gemma":[0.970739,0.002042615,0.002999431,0.00207647,0.0006982797,0.01267734,0.002569047,0.00005129406,0.006146473],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01094613,"threshold_uncertainty_score":0.03661841,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09217394740378554,"score_gpt":0.4726768322864767,"score_spread":0.3805028848826912,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}